Literature DB >> 19218448

Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation.

Sarah Burge1, Daniel P Teufel, Fiona M Townsley, Stefan M V Freund, Mark Bycroft, Alan R Fersht.   

Abstract

The transcription factor p73 belongs to the p53 family of proteins and can transactivate a number of target genes in common with p53. Here, we characterized the interaction of the p73 N terminus with four domains of the transcriptional coactivator p300 and with the negative regulator Mdm2 by using biophysical and cellular measurements. We found that, like p53, the N terminus of p73 contained two distinct transactivation subdomains, comprising residues 10-30 and residues 46-67. The p73 N terminus bound weakly to the Taz1, Kix, and IBiD domains of p300 but with submicromolar affinity for Taz2, in contrast to previous reports. We found weaker binding of the p73 N terminus to the p300 domains in vitro correlated with a significant decrease in transactivation activity in a cell line for the QS and T14A mutants, and tighter binding of the phosphomimetic T14D in vitro correlated with an increase in vivo. Further, we found that phosphorylation of T14 increased the affinity of the p73 N terminus for Taz2 10-fold. The phosphomimetic p73alpha T14D caused increased levels of transactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218448      PMCID: PMC2651247          DOI: 10.1073/pnas.0900383106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15.

Authors:  N Dumaz; D M Milne; D W Meek
Journal:  FEBS Lett       Date:  1999-12-17       Impact factor: 4.124

2.  p300 does not require its acetylase activity to stimulate p73 function.

Authors:  X Zeng; H Lee; Q Zhang; H Lu
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

3.  Solution structure of the TAZ2 (CH3) domain of the transcriptional adaptor protein CBP.

Authors:  R N De Guzman; H Y Liu; M Martinez-Yamout; H J Dyson; P E Wright
Journal:  J Mol Biol       Date:  2000-10-20       Impact factor: 5.469

Review 4.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

5.  DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.

Authors:  Antonio Costanzo; Paola Merlo; Natalia Pediconi; Marcella Fulco; Vittorio Sartorelli; Philip A Cole; Giulia Fontemaggi; Maurizio Fanciulli; Louis Schiltz; Giovanni Blandino; Clara Balsano; Massimo Levrero
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

6.  Definition of the p53 functional domains necessary for inducing apoptosis.

Authors:  J Zhu; S Zhang; J Jiang; X Chen
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

7.  The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.

Authors:  X Zeng; X Li; A Miller; Z Yuan; W Yuan; R P Kwok; R Goodman; H Lu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

8.  Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding.

Authors:  K Sakaguchi; S Saito; Y Higashimoto; S Roy; C W Anderson; E Appella
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

9.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours.

Authors:  A Yang; N Walker; R Bronson; M Kaghad; M Oosterwegel; J Bonnin; C Vagner; H Bonnet; P Dikkes; A Sharpe; F McKeon; D Caput
Journal:  Nature       Date:  2000-03-02       Impact factor: 49.962

Review 10.  p73: Friend or foe in tumorigenesis.

Authors:  Gerry Melino; Vincenzo De Laurenzi; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  18 in total

Review 1.  Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases.

Authors:  Vladimir N Uversky; Vrushank Davé; Lilia M Iakoucheva; Prerna Malaney; Steven J Metallo; Ravi Ramesh Pathak; Andreas C Joerger
Journal:  Chem Rev       Date:  2014-05-15       Impact factor: 60.622

2.  Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-XL.

Authors:  Mi-Kyung Yoon; Bu-Yeon Kim; Ji-Young Lee; Ji-Hyang Ha; Sung Ah Kim; Dong-Hwa Lee; Min-Sung Lee; Mi-Kyung Lee; Jin Sun Choi; Jin Hwa Cho; Jeong-Hoon Kim; Sunhong Kim; Jaewhan Song; Sung Goo Park; Byoung Chul Park; Kwang-Hee Bae; Sang Un Choi; Seung-Wook Chi
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

3.  Conformational selection in the molten globule state of the nuclear coactivator binding domain of CBP.

Authors:  Magnus Kjaergaard; Kaare Teilum; Flemming M Poulsen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-24       Impact factor: 11.205

4.  Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition.

Authors:  Jae-Sun Shin; Ji-Hyang Ha; Dong-Hwa Lee; Kyoung-Seok Ryu; Kwang-Hee Bae; Byoung Chul Park; Sung Goo Park; Gwan-Su Yi; Seung-Wook Chi
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

5.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

6.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

7.  Differences in the transactivation domains of p53 family members: a computational study.

Authors:  Jagadeesh N Mavinahalli; Arumugam Madhumalar; Roger W Beuerman; David P Lane; Chandra Verma
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

Review 8.  Alterations of p63 and p73 in human cancers.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Subcell Biochem       Date:  2014

9.  The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP.

Authors:  Torsten Wurm; Diana G Wright; Nicholas Polakowski; Jean-Michel Mesnard; Isabelle Lemasson
Journal:  Nucleic Acids Res       Date:  2012-03-19       Impact factor: 16.971

10.  DNA damage in oocytes induces a switch of the quality control factor TAp63α from dimer to tetramer.

Authors:  Gregor B Deutsch; Elisabeth M Zielonka; Daniel Coutandin; Tobias A Weber; Birgit Schäfer; Jens Hannewald; Laura M Luh; Florian G Durst; Mohamed Ibrahim; Jan Hoffmann; Frank H Niesen; Aycan Sentürk; Hana Kunkel; Bernd Brutschy; Enrico Schleiff; Stefan Knapp; Amparo Acker-Palmer; Manuel Grez; Frank McKeon; Volker Dötsch
Journal:  Cell       Date:  2011-02-18       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.